ClinicalTrials.Veeva
Menu

Find clinical trials for Endometrial Cancer in Montréal, QC

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Carcinoma
Cancer
Ovarian Cancer
Breast Cancer
Ovarian Epithelial Carcinoma
Triple Negative Breast Cancer
Lung Cancer

Endometrial Cancer trials near Montréal, QC, CAN:

Study of Niraparib and TSR-042 in Recurrent Endometrial Cancer

This is a phase 2 study of investigational drug niraparib and TSR-042 in patients with advanced/recurrent endometrial cancer. The p ...

Active, not recruiting
Endometrial Cancer
Drug: TSR-042
Drug: Niraparib

Phase 2

University Health Network, Toronto
University Health Network, Toronto

Montréal, Quebec, Canada and 6 other locations

study is designed to evaluate the efficacy, safety, and pharmacokinetics of giredestrant monotherapy in participants with Grade 1 endometrioid endometrial...

Enrolling
Endometrial Cancer
Drug: Giredestrant

Phase 2

Roche
Roche

Montreal, Quebec, Canada and 18 other locations

The primary objectives of this study are to compare sacituzumab tirumotecan to Treatment of Physician's Choice (TPC) with respect to progression-free...

Enrolling
Endometrial Cancer
Drug: Paclitaxel
Drug: Doxorubicin

Phase 3

Merck Sharp & Dohme (MSD)
Merck Sharp & Dohme (MSD)

Montréal, Quebec, Canada and 107 other locations

(paclitaxel + carboplatin) followed by maintenance durvalumab with or without olaparib for patients with newly diagnosed advanced or recurrent endometrial...

Active, not recruiting
Endometrial Neoplasms
Biological: durvalumab
Drug: olaparib

Phase 3

AstraZeneca
AstraZeneca

Montreal, Quebec, Canada and 202 other locations

for maintenance selinexor in participants with advanced or recurrent endometrial cancer. Participants with primary stage IV or recu...

Active, not recruiting
Endometrial Cancer
Drug: Matching placebo for selinexor
Drug: Selinexor

Phase 3

Karyopharm Therapeutics
Karyopharm Therapeutics

Montréal, Quebec, Canada and 77 other locations

This study evaluates navtemadlin as maintenance treatment for patients with advanced or recurrent endometrial cancer (EC) who have ...

Enrolling
Endometrial Cancer
Drug: Navtemadlin Placebo
Drug: Navtemadlin

Phase 2, Phase 3

Kartos Therapeutics

Montreal, Canada and 82 other locations

participants with recurrent or primary advanced (Stage III or IV) endometrial cancer....

Active, not recruiting
Neoplasms
Drug: Carboplatin
Drug: Paclitaxel

Phase 3

Tesaro
Tesaro

Montreal, Quebec, Canada and 162 other locations

choice (doxorubicin or paclitaxel) for the treatment of advanced endometrial cancer. Participants will be randomly assigned to rece...

Active, not recruiting
Endometrial Neoplasms
Drug: Pembrolizumab
Drug: Doxorubicin

Phase 3

Eisai
Eisai

Montreal, Quebec, Canada and 168 other locations

+ breast cancer, epithelial ovarian cancer, endometrial cancer, cutaneous melanoma, thyroid cancer, SCLC...

Enrolling
Endometrial Cancer
Small-cell Lung Cancer
Drug: TH1902

Phase 1

Theratechnologies

Montréal, Quebec, Canada and 5 other locations

to other places in the body, it is called advanced or metastatic cancer. Participants in this study must have head and neck squamous cell ca ...

Enrolling
Endometrial Neoplasms
Ovarian Neoplasms
Drug: disitamab vedotin

Phase 2

Seagen
Seagen

Montreal, Quebec, Canada and 30 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems